BUDD-CHIARI SYNDROME IN WOMEN TAKING ORAL CONTRACEPTIVES Newsletter Article 13 February 2013 Pages: 3 - 3
RAPIDLY DEVELOPING OSTEOPOROSIS DURING PREDNISONE THERAPY Newsletter Article 13 February 2013 Pages: 4 - 4
CANCER AND FETAL ABNORMALITY AFTER IMMUNOSUPPRESSIVE THERAPY? Newsletter Article 13 February 2013 Pages: 5 - 5
FORMICATION ASSOCIATED WITH AZATHIOPRINE THERAPY: First Report Newsletter Article 13 February 2013 Pages: 5 - 5
‘DRAMATIC’ REACTION TO NALOXONE REVERSAL OF MORPHINE ANAESTHESIA Newsletter Article 13 February 2013 Pages: 6 - 6
ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS IN CHILDREN Newsletter Article 13 February 2013 Pages: 6 - 6
DIHYDROTACHYSTEROL FOR HAEMODIALYSIS PATIENTS WITH BONE DISEASE Newsletter Article 13 February 2013 Pages: 7 - 7
AND NOW A LONG-TERM STUDY OF 1-α-OHD3 IN RENAL OSTEODYSTROPHY Newsletter Article 13 February 2013 Pages: 9 - 9
CLOFIBRATE: FEWER SIDE-EFFECTS THAN CHLORPROPAMIDE IN DIABETES INSIPIDUS? Newsletter Article 13 February 2013 Pages: 10 - 10
METHYLDOPA IN THE CONTROL OF HYPERTENSION IN PREGNANCY Newsletter Article 13 February 2013 Pages: 11 - 11
SURPRISING DIFFERENCE BETWEEN TWO DELIVERY FORMS OF METHOXSALEN Newsletter Article 13 February 2013 Pages: 12 - 12
ORAL LORAZEPAM IS A BETTER NIGHT SEDATIVE THAN DICHLORAL PHENAZONE Newsletter Article 13 February 2013 Pages: 12 - 12
CHOOSING AN ANTIBIOTIC FOR OSTEOMYELITIS AND SEPTIC ARTHRITIS Newsletter Article 13 February 2013 Pages: 12 - 12
SARALASIN AS A SCREENING TEST FOR RENOVASCULAR HYPERTENSION Newsletter Article 13 February 2013 Pages: 13 - 13
APPARENT INTERACTION OF METHYLDOPA AND LITHIUM CARBONATE Newsletter Article 13 February 2013 Pages: 15 - 16
DOBUTAMINE (‘Dobutrex’) — A new cardiovascular agent from Lilly has just been introduced in the UK Newsletter Article 13 February 2013 Pages: 19 - 19